Literature DB >> 33737444

Patient and public involvement in numerical aspects of trials: a mixed methods theory-informed survey of trialists' current practices, barriers and facilitators.

Beatriz Goulao1, Camille Poisson2, Katie Gillies2.   

Abstract

OBJECTIVE: We aimed to find out if trialists involve patients and the public in numerical aspects of trials, how and what are the barriers and facilitators to doing it.
DESIGN: We developed a survey based on the Theoretical Domains Framework. We used a mixed methods approach to analyse the data and to identify important domains.
SETTING: Online survey targeting UK-based trial units. PARTICIPANTS: Stakeholders working in UK-based clinical trials, 18 years old or over, understand English and agree to take part in the study. OUTCOME MEASURES: Trialists' behaviour of involving patients and the public in numerical aspects of trials and its determinants.
RESULTS: We included 187 respondents. Majority were female (70%), trial managers (67%) and involved public and patient partners in numerical aspects of trials (60%). We found lack of knowledge, trialists' perception of public and patient partners' skills, capabilities and motivations, scarce resources, lack of reinforcement, and lack of guidance were barriers to involving public and patient partners in numerical aspects of trials. Positive beliefs about consequences were an incentive to doing it.
CONCLUSIONS: More training, guidance and funding can help trialists involve patient and public partners in numerical aspects, although they were uncertain about public and patient partners' motivation to be involved. Future research should focus on identifying public and patient partners' motivations and develop strategies to improve the communication of numerical aspects. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical trials; health services administration & management; statistics & research methods

Mesh:

Year:  2021        PMID: 33737444      PMCID: PMC7978289          DOI: 10.1136/bmjopen-2020-046977

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  13 in total

1.  Dissemination of trial results to participants in phase III pragmatic clinical trials: an audit of trial investigators intentions.

Authors:  M Zulfiqar Raza; Hanne Bruhn; Katie Gillies
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

2.  Validation of the theoretical domains framework for use in behaviour change and implementation research.

Authors:  James Cane; Denise O'Connor; Susan Michie
Journal:  Implement Sci       Date:  2012-04-24       Impact factor: 7.327

3.  A little more conversation please? Qualitative study of researchers' and patients' interview accounts of training for patient and public involvement in clinical trials.

Authors:  Louise Dudley; Carrol Gamble; Alison Allam; Philip Bell; Deborah Buck; Heather Goodare; Bec Hanley; Jennifer Preston; Alison Walker; Paula Williamson; Bridget Young
Journal:  Trials       Date:  2015-04-27       Impact factor: 2.279

4.  Priorities for methodological research on patient and public involvement in clinical trials: A modified Delphi process.

Authors:  Anna Kearney; Paula Williamson; Bridget Young; Heather Bagley; Carrol Gamble; Simon Denegri; Delia Muir; Natalie A Simon; Stephen Thomas; Jim T Elliot; Helen Bulbeck; Joanna C Crocker; Claire Planner; Claire Vale; Mike Clarke; Tim Sprosen; Kerry Woolfall
Journal:  Health Expect       Date:  2017-06-15       Impact factor: 3.377

5.  Barriers and facilitators to healthcare professional behaviour change in clinical trials using the Theoretical Domains Framework: a case study of a trial of individualized temperature-reduced haemodialysis.

Authors:  Justin Presseau; Brittany Mutsaers; Ahmed A Al-Jaishi; Janet Squires; Christopher W McIntyre; Amit X Garg; Manish M Sood; Jeremy M Grimshaw
Journal:  Trials       Date:  2017-05-22       Impact factor: 2.279

6.  Patient and public involvement (PPI) in UK surgical trials: a survey and focus groups with stakeholders to identify practices, views, and experiences.

Authors:  Joanna C Crocker; Keira Pratt-Boyden; Jenny Hislop; Sian Rees; Louise Locock; Sophie Olszowski; Alan Chant; Shaun Treweek; Jonathan A Cook; Kerry Woolfall; Nicola Farrar; Jennifer Bostock; Richard Bulbulia
Journal:  Trials       Date:  2019-02-11       Impact factor: 2.279

7.  "About sixty per cent I want to do it": Health researchers' attitudes to, and experiences of, patient and public involvement (PPI)-A qualitative interview study.

Authors:  Anne-Marie Boylan; Louise Locock; Richard Thomson; Sophie Staniszewska
Journal:  Health Expect       Date:  2019-03-29       Impact factor: 3.377

Review 8.  Patient and public involvement in the design of clinical trials: An overview of systematic reviews.

Authors:  Amy Price; Loai Albarqouni; Jo Kirkpatrick; Mike Clarke; Su May Liew; Nia Roberts; Amanda Burls
Journal:  J Eval Clin Pract       Date:  2017-10-27       Impact factor: 2.431

9.  Measuring determinants of implementation behavior: psychometric properties of a questionnaire based on the theoretical domains framework.

Authors:  Johanna M Huijg; Winifred A Gebhardt; Elise Dusseldorp; Marieke W Verheijden; Nicolette van der Zouwe; Barend J C Middelkoop; Mathilde R Crone
Journal:  Implement Sci       Date:  2014-03-19       Impact factor: 7.327

10.  Patients' and researchers' experiences with a patient board for a clinical trial on urinary tract infections.

Authors:  Imke Schilling; Heike Behrens; Jutta Bleidorn; Ildikó Gágyor; Claudia Hugenschmidt; Hannah Jilani; Guido Schmiemann; Ansgar Gerhardus
Journal:  Res Involv Engagem       Date:  2019-11-28
View more
  2 in total

1.  How can behavioural science help us design better trials?

Authors:  Katie Gillies; Jamie Brehaut; Taylor Coffey; Eilidh M Duncan; Jill J Francis; Spencer P Hey; Justin Presseau; Charles Weijer; Marion K Campbell
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

2.  Patient and public involvement in numerical aspects of trials (PoINT): exploring patient and public partners experiences and identifying stakeholder priorities.

Authors:  Beatriz Goulao; Hanne Bruhn; Marion Campbell; Craig Ramsay; Katie Gillies
Journal:  Trials       Date:  2021-07-28       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.